These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18589712)

  • 1. [Gamma-scintigraphy in assessment cardioresynchronizing therapy at chronic heart failure].
    Minin SM; Chernov VI; Savenkova GM; Lishmanov IuB
    Klin Med (Mosk); 2008; 86(5):24-7. PubMed ID: 18589712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
    St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
    Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities.
    Becker M; Altiok E; Ocklenburg C; Krings R; Adams D; Lysansky M; Vogel B; Schauerte P; Knackstedt C; Hoffmann R
    JACC Cardiovasc Imaging; 2010 May; 3(5):472-81. PubMed ID: 20466342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term results of cardiac resynchronisation therapy for patients with severe heart failure].
    Bulava A; Lukl J; Hutyra M; Marek D
    Vnitr Lek; 2007 Nov; 53(11):1153-63. PubMed ID: 18277624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in left ventricular diastolic function in chronic ischemic heart failure. Assessment by radionuclide angiography.
    Bareiss P; Facello A; Constantinesco A; Demangeat JL; Brunot B; Arbogast R; Roul G
    Circulation; 1990 Feb; 81(2 Suppl):III71-7. PubMed ID: 2297884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?
    Bellenger NG; Burgess MI; Ray SG; Lahiri A; Coats AJ; Cleland JG; Pennell DJ
    Eur Heart J; 2000 Aug; 21(16):1387-96. PubMed ID: 10952828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of longitudinal and radial two-dimensional strain imaging versus Doppler tissue echocardiography in predicting long-term response to cardiac resynchronization therapy.
    Knebel F; Schattke S; Bondke H; Walde T; Eddicks S; Reibis R; Baumann G; Borges AC
    J Am Soc Echocardiogr; 2007 Apr; 20(4):335-41. PubMed ID: 17400111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Slade M; Carolan S; Vallejo E; Wackers FJ
    Eur Heart J; 2001 May; 22(10):849-56. PubMed ID: 11350094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume overload modulates effects of cardiac resynchronization therapy independently of myocardial reperfusion: results of the RESYNC study.
    Gimelli A; Stanislao M; Valle G; Frumento P; Zanco P; Ometto R; Inglese E; Martino G; Startari U; Bertelli P; Marzullo P
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):575-81. PubMed ID: 17667027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography.
    Boriani G; Valzania C; Fallani F; Biffi M; Martignani C; Saporito D; Ziacchi M; Diemberger I; Greco C; Bertini M; Domenichini G; Levorato M; Franchi R; Branzi A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S43-6. PubMed ID: 17302715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.